Linden, NJ, United States of America

Robert T Goegelman

This inventor holds 25 USPTO granted patents, primarily in Antibiotic Production. Top assignees: Merck + Co., Inc., Other. Active years: 1976-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert T Goegelman. Retrieved from https://idiyas.com/inventor/robert-t-goegelman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 10

Forward Citations = 354(Granted Patents)


Company Filing History:


Years Active: 1976-1994

Loading Chart...
Areas of Expertise:
Immunosuppressive Cyclosporin
Anthelmintic Compounds
Fermentation Products
Avermectin
Thienamycin
Macrolides
Streptomyces
Bioconversion
Lipophilic Materials
C-076 Compounds
Novel Antibiotics
Microorganisms
25 patents (USPTO):Explore Patents

Title: Robert T. Goegelman - Innovative Inventor from Linden, NJ

Introduction: Robert T. Goegelman is a renowned inventor hailing from Linden, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Robert T. Goegelman holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: Throughout his illustrious career, Robert T. Goegelman has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many.

Collaborations: Robert T. Goegelman has collaborated with leading tech companies and research institutions, further solidifying his reputation as a visionary inventor with a keen eye for transformative ideas.

Conclusion: Robert T. Goegelman's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors, inspiring future generations to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…